Antimicrobial Stewardship & Healthcare Epidemiology (Jan 2023)

Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients

  • Sarah A. Drost,
  • Irina Rajakumar,
  • Elissa Rennert-May

DOI
https://doi.org/10.1017/ash.2023.133
Journal volume & issue
Vol. 3

Abstract

Read online

In this point-prevalence survey followed by prospective audit and feedback at 4 tertiary-care hospitals in Calgary, Alberta, Canada, we evaluated whether intravenous amoxicillin-clavulanate may be used as a narrower-spectrum alternative to intravenous piperacillin-tazobactam for patients admitted to general surgery services.